Importantly, recent work from our group showed that inhibiting FKBP5 via broad-acting and selective FKBP5 inhibitors has efficacy in decreasing comorbid PTSD/AUD-like behaviors in rats [39, 53]. The gene discussed is FKBP5; the disease is post-traumatic stress disorder.